Literature DB >> 32631197

Facilitating Both Evidence and Access: Improving FDA's Accelerated Approval and Expanded Access Pathways.

Holly Fernandez Lynch1, Alison Bateman-House1.   

Abstract

Mesh:

Year:  2020        PMID: 32631197     DOI: 10.1177/1073110520935352

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


× No keyword cloud information.
  3 in total

1.  From "Ought" to "Is": Surfacing Values in Patient and Family Advocacy in Rare Diseases.

Authors:  Meghan C Halley
Journal:  Am J Bioeth       Date:  2021-12       Impact factor: 11.229

Review 2.  FDA Drug Approval and the Ethics of Desperation.

Authors:  Emily A Largent; Andrew Peterson; Holly Fernandez Lynch
Journal:  JAMA Intern Med       Date:  2021-12-01       Impact factor: 21.873

Review 3.  Reviewing fair subject selection considerations for the unique case of post sequelae COVID-19 translational studies.

Authors:  E M Smith; E E Anderson; R Deer; J Prochaska; K Bohn; S Croisant
Journal:  J Clin Transl Sci       Date:  2022-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.